ASSEMBLY BIOSCIENCES, INC. (ASMB) Form 424B5 — May 22, 2026
Assembly Biosciences, Inc. (ASMB) filed a preliminary prospectus supplement for a follow-on equity offering of common stock and pre-funded warrants. The filing is subject to completion, meaning the final offering price, number of shares, and gross proceeds have not yet been determined. Gilead Sciences has indicated an interest in purchasing shares pro rata to its existing ownership, though this is not a binding commitment.
Key figures
- Cash Position
- 198600000
- Shares Outstanding
- 15892353
- Shelf Capacity
- $400,000,000
- Outstanding PSUs
- 225000
- Outstanding RSUs
- 664935
- Outstanding Options
- 1171159
- Net Tangible Book Value
- $198.6 million
- Last Reported Sale Price
- $26.26
- Outstanding Warrants17
- 814000
- Outstanding Warrants21.60
- 8673477
- Net Tangible Book Value Per Share
- $12.50
Price after filing
1 day: 0.0%7 days: +4.6%30 days: -7.8%
Close on the filing date to close N calendar days later (from $26.50). Historical, not a forecast.
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.